Industry News

Nov 20, 2014

New technology could 'light up' cancer cells during surgery and improve cancer surgery outcomes: First human clinical trials underway

On Target Laboratories LLCand Purdue University are clinically investigating optical imaging technology that could "light up" cancer cells and help surgeons remove more cancerous tissue than... Read More
Nov 20, 2014

'Jekyll and Hyde' molecule is key to new personalised medicine for prostate cancer

Researchers who have uncovered the 'monstrous' hidden nature of a molecule involved in prostate cancer say the findings could herald a new form of personalised medicine for patients, with doctors... Read More
Nov 20, 2014

How new insight into cells could lead to better drugs

A new insight into immune cells by scientists at The University of Manchester could lead to more effective drug treatments. Read More
Nov 20, 2014

Early results show response to new drug in patients with lymphomas and advanced solid tumours

Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial. Read More
Nov 20, 2014

Researchers identify biological indicator of response to new ovarian cancer drug

Researchers have found a way of identifying which ovarian cancer patients are likely to respond well to a new anti-cancer drug called rucaparib. Read More
Nov 20, 2014

Study finds more breast cancer patients opting for mastectomy

Far more breast cancer patients are choosing to undergo mastectomy, including removal of both breasts, instead of choosing breast conservation surgery even when they have early stage disease that... Read More
Nov 20, 2014

Study finds early diagnosis and cord blood transplantation prevents permanent brain damage from rare inherited disease

Umbilical cord blood from unrelated donors can halt the progression of the neurodegenerative disease Hurler syndrome if performed before the affected child is less than 9 months old, according to a... Read More
Nov 20, 2014

Mutations identified that are expressed within melanoma tumors that predict effective responses to a groundbreaking immunotherapy

A team led by Ludwig and Memorial Sloan Kettering (MSK) researchers has published a landmark study on the genetic basis of response to a powerful cancer therapy known as immune checkpoint blockade. Read More
Nov 20, 2014

New potential target coating for drug-eluting stents identified by big data study

A new study has identified an FDA approved cancer drug, crizotinib, as a possible new coating for drug-eluting stents. Read More
Nov 20, 2014

The Affordable Care Act in Kentucky, one year later

One year ago, Michael Stillman, M.D., and his colleague, Monalisa Tailor, M.D. Read More
Next Page